Leverkusen, Germany

Michael Härter


Average Co-Inventor Count = 9.6

ph-index = 3

Forward Citations = 63(Granted Patents)


Company Filing History:


Years Active: 2002-2004

Loading Chart...
5 patents (USPTO):

Title: The Innovative Contributions of Michael Härtner

Introduction

Michael Härtner, an accomplished inventor based in Leverkusen, Germany, has made significant strides in the field of pharmaceutical innovations. With a robust portfolio comprising five patents, Härtner's work has predominantly focused on developing compounds with therapeutic applications. His inventive spirit and dedication to research have set new benchmarks in his field.

Latest Patents

Härtner's latest patents reflect his commitment to advancing medical science. Among these is the patent for "Biphenyl and biphenyl-analogous compounds as integrin antagonists," which highlights his contribution to targeted therapies. Additionally, he has developed "Substituted amidoalkyl-uracils and their use," showcasing his innovation in drug formulation and delivery.

Career Highlights

Throughout his distinguished career, Härtner has notably worked with leading companies, including Bayer Aktiengesellschaft and Beiersdorf AG. These roles have provided him with a platform to leverage his expertise in pharmaceuticals and contribute to groundbreaking advancements within these organizations.

Collaborations

Michael Härtner has collaborated with several esteemed colleagues, including Markus Albers and Klaus Urbahns. These partnerships have fostered an environment of creativity and innovation, driving impactful research and development in the pharmaceutical sector.

Conclusion

In summary, Michael Härtner's contributions as an inventor are significant in the realm of pharmaceutical innovations. His achievements, including multiple patents and collaborations with major companies, underscore his role in advancing medical research. As the industry continues to evolve, Härtner's work remains a vital part of the ongoing quest for innovative solutions in healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…